相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Urinary Biomarkers for Diagnosis of Bladder Cancer A Systematic Review and Meta-analysis
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2015)
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
Bernd J. Schmitz-Draeger et al.
UROLOGIA INTERNATIONALIS (2015)
Method development for simultaneous analyses of multiple legacy and emerging organic chemicals in sediments
Jiehong Guo et al.
JOURNAL OF CHROMATOGRAPHY A (2014)
Considerations on the use of urine markers in the management of with high-grade non-muscle-invasive bladder cancer
Ashish M. Kamat et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
Marko Babjuk et al.
EUROPEAN UROLOGY (2011)
Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer
G. Mowatt et al.
HEALTH TECHNOLOGY ASSESSMENT (2010)
Cystoscopy Revisited as the Gold Standard for Detecting Bladder Cancer Recurrence: Diagnostic Review Bias in the Randomized, Prospective CEFUB Trial
Madelon N. M. van der Aa et al.
JOURNAL OF UROLOGY (2010)
Urine Cytology in the Evaluation of Urological Malignancy Revisited: Is It Still Necessary?
Opeyemi Adegboyega Falebita et al.
UROLOGIA INTERNATIONALIS (2010)
Urinary cytology and quantitative BTA and UBC tests in surveillance of patients with pTapT1 bladder urothelial carcinoma
M. Babjuk et al.
UROLOGY (2008)
Is routine urine cytology useful in the haematuria clinic?
S. Viswanath et al.
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND (2008)
Urinary NMP22® BladderChek® test in the diagnosis of superficial bladder cancer
PMJ Moonen et al.
EUROPEAN UROLOGY (2005)
Bladder tumor markers beyond cytology:: International consensus panel on bladder tumor markers
VB Lokeshwar et al.
UROLOGY (2005)
Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma
OW Hakenberg et al.
UROLOGY (2004)
Clinical utility of cytokeratins as tumor markers
V Barak et al.
CLINICAL BIOCHEMISTRY (2004)
Tumor markers in the diagnosis of primary bladder cancer. A systematic review
AS Glas et al.
JOURNAL OF UROLOGY (2003)
Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analyses
Y Lotan et al.
UROLOGY (2003)
Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence
H Boman et al.
JOURNAL OF UROLOGY (2002)
Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors
A Giannopoulos et al.
JOURNAL OF UROLOGY (2001)
Comparison of two qualitative assays, the UBC rapid test and the BTA stat test, in the diagnosis of urothelial cell carcinoma of the bladder
C Mian et al.
UROLOGY (2000)
Preliminary report of the clinical performance of a new urinary bladder cancer antigen test: comparison to voided urine cytology in the detection of transitional cell carcinoma of the bladder
S Sumi et al.
CLINICA CHIMICA ACTA (2000)
分享论文
